Halo !!! Saya Kang Ismet, ini adalah blog tentang AMP HTML dan cara penerapannya

Immunotherapy; Aetiology

Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Here’s a Sample of My Raw Data -> In Excel -> Leaner (Excel) -> with dictionary


The identification of bacteria and bacterial products that will help balance the immune system of humans and protect them against cancer and ...

On the plus side, these new therapies, which target specific mutations in tumors or stimulate the body's immune system to attack cancer, are seen as ...

There are also many different types of cancer, each of which responds ... since cancer stem cells are difficult for the immune system to recognize.

About 40,000 Malaysians are diagnosed with cancer each year while ... by adjusting and upgrading the patient's own immune system to target cancer ...



Science Daily Cancer News

Telomeres are short stretches of repeated nucleotides that protect the ends of chromosomes. In somatic cells, these protective sequences become shorter with each cellular replication until a critical length is reached, which can trigger cell death. At the conclusion of their study, the authors conclude, "We speculate that long telomeres may represent a survival advantage for cancer cells, allowing multiple cell divisions leading to high cancer mortality."

Two cancer-suppressing proteins that could hold a key to controlling cancer cell growth and development have been discovered by researchers. The previously undiscovered proteins were found during ongoing research on the ubiquitin system.

Targeting the genetic drivers of cancer works in clinical trials, but cancers often resurface shortly thereafter. Immunotherapy -- which primes a patient's immune cells to attack tumors -- offers a longer-lasting response, but only in a fraction of people. The way forward, argue experts, is to shift funding and research priorities so that these complementary approaches can be combined.


New research shines a light on identifying ‘hot spots’ in drug-resistant mutations involving a certain protein found to influence cancer growth.